EA200000011A1 - Средства и способы доставки лекарственных препаратов для терапии вирусных и бактериальных инфекций и синдромов истощения - Google Patents

Средства и способы доставки лекарственных препаратов для терапии вирусных и бактериальных инфекций и синдромов истощения

Info

Publication number
EA200000011A1
EA200000011A1 EA200000011A EA200000011A EA200000011A1 EA 200000011 A1 EA200000011 A1 EA 200000011A1 EA 200000011 A EA200000011 A EA 200000011A EA 200000011 A EA200000011 A EA 200000011A EA 200000011 A1 EA200000011 A1 EA 200000011A1
Authority
EA
Eurasian Patent Office
Prior art keywords
viral
methods
bacterial infections
delivery
syndrome
Prior art date
Application number
EA200000011A
Other languages
English (en)
Inventor
Мишель Олга Патрисия Джиэстейра Виссер
Original Assignee
Криопрезервейшн Текнолоджиз Сс
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,425 external-priority patent/US5935597A/en
Application filed by Криопрезервейшн Текнолоджиз Сс filed Critical Криопрезервейшн Текнолоджиз Сс
Publication of EA200000011A1 publication Critical patent/EA200000011A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Заявляются новые средства доставки лекарственных веществ, способы и терапевтические композиции для лечения вирусных и бактериальных инфекций и синдромов истощения у больных животных, включая человека. Согласно изобретению, больному, нуждающемуся в лечении, вводится полярное соединение, например диметилформамид или диметилсульфоксид, предпочтительно через кожу. Дополнительно изобретение предоставляет вакцину, полученную на основе антител больного, который подвергался анти-ВИЧ-терапии по способу изобретения.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200000011A 1997-06-13 1998-06-09 Средства и способы доставки лекарственных препаратов для терапии вирусных и бактериальных инфекций и синдромов истощения EA200000011A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/874,425 US5935597A (en) 1995-12-15 1997-06-13 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
PCT/US1998/011956 WO1998056325A1 (en) 1997-06-13 1998-06-09 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes

Publications (1)

Publication Number Publication Date
EA200000011A1 true EA200000011A1 (ru) 2000-08-28

Family

ID=25363728

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000011A EA200000011A1 (ru) 1997-06-13 1998-06-09 Средства и способы доставки лекарственных препаратов для терапии вирусных и бактериальных инфекций и синдромов истощения

Country Status (34)

Country Link
EP (1) EP1011567A1 (ru)
JP (1) JP4531141B2 (ru)
KR (1) KR20010013709A (ru)
CN (1) CN1260703A (ru)
AP (1) AP1629A (ru)
AR (1) AR012970A1 (ru)
AU (1) AU7831598A (ru)
BG (1) BG103997A (ru)
BR (1) BR9810095A (ru)
CA (1) CA2295176A1 (ru)
CZ (1) CZ298510B6 (ru)
EA (1) EA200000011A1 (ru)
EE (1) EE9900562A (ru)
ES (1) ES2161187B1 (ru)
FI (1) FI19992648A (ru)
GB (1) GB2341319B (ru)
HU (1) HUP0003034A2 (ru)
ID (1) ID23516A (ru)
IL (2) IL133396A0 (ru)
IS (1) IS5289A (ru)
LT (1) LT4714B (ru)
LV (1) LV12490B (ru)
NO (1) NO996117L (ru)
NZ (1) NZ501669A (ru)
OA (1) OA11307A (ru)
PL (1) PL196256B1 (ru)
RO (1) RO121252B1 (ru)
SI (1) SI20191A (ru)
SK (1) SK172299A3 (ru)
TN (1) TNSN98086A1 (ru)
TR (1) TR200000540T2 (ru)
WO (1) WO1998056325A1 (ru)
YU (1) YU66099A (ru)
ZA (1) ZA984649B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2006003648A0 (en) * 2003-12-05 2006-06-30 Namibia Medical Invest Pty Ltd Patch

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide
WO1993016992A1 (en) * 1992-02-20 1993-09-02 Merrell Dow Pharmaceuticals Inc. Sulfonic acid derivatives in the treatment of viral diseases
NZ330642A (en) * 1995-12-15 2000-06-23 Cryopreservation Tech Cc Transdermal amide composition for organ cryopreservation and vaccine for treating microbial and/or virus infections

Also Published As

Publication number Publication date
LV12490A (en) 2000-06-20
BR9810095A (pt) 2001-11-13
YU66099A (sh) 2002-10-18
PL338439A1 (en) 2000-11-06
EE9900562A (et) 2000-06-15
NO996117L (no) 2000-02-11
GB9929189D0 (en) 2000-02-02
IS5289A (is) 1999-12-08
AP1629A (en) 2006-07-11
AU7831598A (en) 1998-12-30
JP4531141B2 (ja) 2010-08-25
CN1260703A (zh) 2000-07-19
GB2341319B (en) 2002-02-27
ES2161187A1 (es) 2001-11-16
SI20191A (sl) 2000-10-31
JP2002511862A (ja) 2002-04-16
NO996117D0 (no) 1999-12-10
IL133396A0 (en) 2001-04-30
SK172299A3 (en) 2000-09-12
IL133396A (en) 2006-10-05
ES2161187B1 (es) 2003-08-16
ZA984649B (en) 1999-12-17
AR012970A1 (es) 2000-11-22
KR20010013709A (ko) 2001-02-26
FI19992648A (fi) 2000-02-03
TR200000540T2 (tr) 2000-09-21
HUP0003034A2 (hu) 2000-12-28
CA2295176A1 (en) 1998-12-17
TNSN98086A1 (fr) 2005-03-15
EP1011567A4 (en) 2000-06-28
AP9901708A0 (en) 1999-12-31
GB2341319A (en) 2000-03-15
LT99148A (en) 2000-07-25
PL196256B1 (pl) 2007-12-31
OA11307A (en) 2003-10-24
RO121252B1 (ro) 2007-02-28
CZ9904473A3 (cs) 2001-03-14
WO1998056325A1 (en) 1998-12-17
LT4714B (lt) 2000-10-25
NZ501669A (en) 2001-09-28
LV12490B (en) 2000-12-20
ID23516A (id) 2000-04-27
EP1011567A1 (en) 2000-06-28
CZ298510B6 (cs) 2007-10-24
BG103997A (en) 2001-07-31

Similar Documents

Publication Publication Date Title
CY1106152T1 (el) Νεα ανοσογονα αντι-hiv (ανατοξινες), μεθοδοι παρασκευης και εφαρμογη στην προληψη και στην αγωγη του aids
FI884013A0 (fi) Konjugat av cytokiner med immunoglobuliner.
RU94022480A (ru) Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с
TR199903053T2 (xx) Benzimidazol t�revleri.
DE69232263T2 (de) Radikalfänger ("spin traps") zur behandlung von mit oxidation von lipiden und proteinen verbundenen erkrankungen
MY117892A (en) Therapeutic compounds
DK1151009T3 (da) Antimikrobielt/endotoksin-neutraliserende polypeptid
DE60237721D1 (de) Kombinationstherapie mit omega-interferon zur behandlung von hepatitis c virus oder gelbfieber virus infektionen
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
DE60043886D1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
DE69929616D1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
EA200000011A1 (ru) Средства и способы доставки лекарственных препаратов для терапии вирусных и бактериальных инфекций и синдромов истощения
ATE185274T1 (de) Therapeutisches mittel gegen drohenden abortus
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
EA199800770A1 (ru) Лекарственный препарат для терапевтического лечения вирусного гепатита
EA200400535A1 (ru) ПОДАВЛЕНИЕ ВИРУСОВ n-ДОКОСАНОЛОМ
WO1999038524A3 (en) Therapeutic administration of low density lipoprotein receptor for viral infections and immune regulation
EA199700353A1 (ru) Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции
MC2306A1 (fr) Peptides bloquant les infections par le virus de l'immunodeficience humaine et methode de leur utilisation
FR2792639B1 (fr) Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
MX9400210A (es) Tratamiento de infecciones virales.